What is Cyclopharm?
Founded in 2005 and headquartered in Kingsgrove, New South Wales, Australia, Cyclopharm is a prominent pharmaceutical manufacturer specializing in medical and health products. The company serves both business-to-business (B2B) and business-to-consumer (B2C) markets, with an operational footprint extending across Oceania. As a publicly traded entity with a fiscal year ending December 31, Cyclopharm's core activities encompass engineering, operations, and the development of advanced medical technologies.
How much funding has Cyclopharm raised?
Cyclopharm has raised a total of $13.3M across 1 funding round:
Share Placement
$13.3M
Share Placement (2024): $13.3M, investors not publicly disclosed
What's next for Cyclopharm?
The substantial enterprise-level funding, including the recent major strategic investment, positions Cyclopharm for accelerated expansion and innovation. This influx of capital is likely to fuel advancements in its engineering and operations, potentially leading to the development of new medical technologies and the broadening of its market reach within Oceania and beyond. The company's focus on both B2B and B2C segments suggests a strategy aimed at comprehensive market penetration and diversified revenue streams.
See full Cyclopharm company page
